SHORTENING INTERVAL INJECTION OF ADALIMUMAB IS MORE EFFICIENT THAN DOUBLING DOSE IN CROHN'S DISEASE PATIENTS WITH LOSS OF RESPONSE

Nicolas Duveau  1     Maria Nachury  1     Medina Boualit  1     Romain Gerard  1     Julien Branche  2     Vincent Maunoury  1     Pierre Desreumaux  2     Benjamin Pariente  3    
1 CHRU Lille, Universit√© Lille 2,Lille,France
2 CHRU Lille, Universit√© Lille 2,Lille ,France
3 CHRU Lille, Unive

Conference
UEG Week 2015

Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing